Page last updated: 2024-11-05

trapidil and Pulmonary Arterial Hypertension

trapidil has been researched along with Pulmonary Arterial Hypertension in 1 studies

Trapidil: A coronary vasodilator agent.

Pulmonary Arterial Hypertension: A progressive rare pulmonary disease characterized by high blood pressure in the PULMONARY ARTERY.

Research Excerpts

ExcerptRelevanceReference
"The increase in thickening of the arterial wall of pulmonary arterial hypertension (PAH) includes cellular proliferation as well as matrix deposition and interrupted internal elastic lamina (IEL) consisting of a thick homogeneous sheet of elastin."3.96Endothelin-1 induces lysyl oxidase expression in pulmonary artery smooth muscle cells. ( Dewachter, C; Dewachter, L; Ieda, M; Maruyama, H; Naeije, R; Rondelet, B; Sakai, S, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Maruyama, H1
Sakai, S1
Dewachter, L1
Dewachter, C1
Rondelet, B1
Naeije, R1
Ieda, M1

Other Studies

1 other study available for trapidil and Pulmonary Arterial Hypertension

ArticleYear
Endothelin-1 induces lysyl oxidase expression in pulmonary artery smooth muscle cells.
    Canadian journal of physiology and pharmacology, 2020, Volume: 98, Issue:9

    Topics: Case-Control Studies; Cell Proliferation; Cells, Cultured; Collagen; Elastin; Endothelin-1; Epoprost

2020